MiMedx Group agrees to $1.5 million settlement for SEC charges of accounting fraud
MLex Summary: The US Securities and Exchange Commission announced it has settled allegations that biotech company MiMedx Group defrauded investors by misstating the company’s revenue and attempted to cover up the...To view the full article, register now.
Already a subscriber? Click here to view full article